CereVasc

Charlestown, United States

CereVasc is a medical device company that develops a minimally invasive treatment option for communicating hydrocephalus.

$85.0M raised

Jun 2026

Series C

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has CereVasc raised?

CereVasc has raised $85.0M in total funding. The most recent round was Series C. The last funding was announced in June 2026.

Who are CereVasc's investors?

CereVasc's investors include Perceptive Advisors, Bain Capital Life Sciences, Medtronic, Johnson & Johnson Innovation, Piper Sandler.

Where is CereVasc headquartered?

CereVasc is headquartered in Charlestown, United States.

What does CereVasc do?

CereVasc is a medical device company that develops a minimally invasive treatment option for communicating hydrocephalus.

What stage is CereVasc at?

CereVasc is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 4, 2026.

MLA

"CereVasc — Funding & Investors." VCBacked, June 4, 2026, https://www.vcbacked.co/company/cerevasc. Accessed July 3, 2026.

APA

VCBacked. (2026). CereVasc — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cerevasc

Wikipedia (cite web)

{{cite web |title=CereVasc — Funding & Investors |url=https://www.vcbacked.co/company/cerevasc |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 4, 2026.